Team

Team

Team

Led by an experienced and committed team

Our team brings decades of collective expertise in clinical and drug development, ensuring comprehensive knowledge and experience in advancing innovative cancer therapies.

Led by an experienced and committed team

Our team brings decades of collective expertise in clinical and drug development, ensuring comprehensive knowledge and experience in advancing innovative cancer therapies.

Led by an experienced and committed team

Our team brings decades of collective expertise in clinical and drug development, ensuring comprehensive knowledge and experience in advancing innovative cancer therapies.

Geordan Pursglove

Geordan Pursglove
CEO

An accomplished executive and entrepreneur with 10+ years of experience in M&A, capital markets, strategy, and operations. Known for innovative leadership across tech, logistics, CX, sports, and marketing, he excels at scaling businesses, raising capital, and executing transformative strategies in public and private markets with a strong, value-driven approach.

Bas van der Baan
CSO

Biotechnology Executive with more than 20 years experience in bringing innovation to the patient. Most recently the Chief Clinical Officer of Agendia.

Specialized in precision oncology and business development. Extensive experience in clinical development overseeing numerous clinical trials from start to publication.

Peter Stazzone, Chief Financial Officer

Peter Stazzone
CFO

Seasoned CFO with 25 years of expertise in finance operations management and accounting across start-ups, high-growth ventures, and multi-billion-dollar enterprises. Since 2018, he has served on the Board of Directors of Beyond Commerce and as Chairman of the Audit Committee, Peter holds an MBA in Finance from DePaul University and a BS in Accounting from the University of Illinois at Urbana-Champaign and is a Certified Public Accountant (CPA).

Supported by world-class experts

Our Scientific Advisory Committee is comprised of esteemed renowned key opinion leaders in the fields of clinical medicine and oncology.

Prof. René Bernards

Prof. René Bernards (Chair)

  • Leader in the field of molecular carcinogenesis
  • Extensive experience in cancer drug development
  • Cancer Institute in Amsterdam
Stephen Forman, MD

Stephen Forman, MD

  • Internationally recognized expert in hematological cancers
  • Professor of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center
Yun Yen MD, PhD, FACP

Yun Yen MD, PhD, FACP

  • Distinguished cancer investigator
  • Former Chairman Mol. Pharmacology City of Hope
  • Former President of Taipei Medical University